Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer

Clinical trial NCT06355024 · COMPLETED

Trial details

NCT number: NCT06355024
Sponsor: Fudan University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Triple-negative Breast Cancer

Start date: 2024-05-11
Primary completion: 2025-01-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.